Literature DB >> 22762014

Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

Eva-Maria Mandelkow1, Eckhard Mandelkow.   

Abstract

Tau represents the subunit protein of one of the major hallmarks of Alzheimer disease (AD), the neurofibrillary tangles, and is therefore of major interest as an indicator of disease mechanisms. Many of the unusual properties of Tau can be explained by its nature as a natively unfolded protein. Examples are the large number of structural conformations and biochemical modifications (phosphorylation, proteolysis, glycosylation, and others), the multitude of interaction partners (mainly microtubules, but also other cytoskeletal proteins, kinases, and phosphatases, motor proteins, chaperones, and membrane proteins). The pathological aggregation of Tau is counterintuitive, given its high solubility, but can be rationalized by short hydrophobic motifs forming β structures. The aggregation of Tau is toxic in cell and animal models, but can be reversed by suppressing expression or by aggregation inhibitors. This review summarizes some of the structural, biochemical, and cell biological properties of Tau and Tau fibers. Further aspects of Tau as a diagnostic marker and therapeutic target, its involvement in other Tau-based diseases, and its histopathology are covered by other chapters in this volume.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22762014      PMCID: PMC3385935          DOI: 10.1101/cshperspect.a006247

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  251 in total

Review 1.  Slow axonal transport and the genesis of neuronal morphology.

Authors:  Peter W Baas; Daniel W Buster
Journal:  J Neurobiol       Date:  2004-01

2.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study.

Authors:  J P Brion; A M Couck; E Passareiro; J Flament-Durand
Journal:  J Submicrosc Cytol       Date:  1985-01

3.  Microtubule-associated proteins connect microtubules and neurofilaments in vitro.

Authors:  E J Aamodt; R C Williams
Journal:  Biochemistry       Date:  1984-12-04       Impact factor: 3.162

4.  Radioimmunoassay for tubulin: a quantitative comparison of the tubulin content of different established tissue culture cells and tissues.

Authors:  G Hiller; K Weber
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

5.  Calmodulin binds to both microtubule-associated protein 2 and tau proteins.

Authors:  Y C Lee; J Wolff
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

6.  Characterization by atomic force microscopy of Alzheimer paired helical filaments under physiological conditions.

Authors:  F Moreno-Herrero; M Pérez; A M Baró; J Avila
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

Review 7.  Synaptic slaughter in Alzheimer's disease.

Authors:  Paul D Coleman; Pamela J Yao
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

8.  Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid.

Authors:  Olaf Goldbaum; Malte Oppermann; Melanie Handschuh; Deepa Dabir; Bin Zhang; Mark S Forman; John Q Trojanowski; Virginia M-Y Lee; Christiane Richter-Landsberg
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

9.  Evidence for actin filament-microtubule interaction mediated by microtubule-associated proteins.

Authors:  L M Griffith; T D Pollard
Journal:  J Cell Biol       Date:  1978-09       Impact factor: 10.539

10.  Microtubules provide directional cues for polarized axonal transport through interaction with kinesin motor head.

Authors:  Takao Nakata; Nobutaka Hirokawa
Journal:  J Cell Biol       Date:  2003-09-15       Impact factor: 10.539

View more
  273 in total

Review 1.  Deciphering Alzheimer disease.

Authors:  Dennis Selkoe; Eckhard Mandelkow; David Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

3.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

Review 4.  Multimodality Review of Amyloid-related Diseases of the Central Nervous System.

Authors:  Michelle M Miller-Thomas; Adam L Sipe; Tammie L S Benzinger; Jonathan McConathy; Sarah Connolly; Katherine E Schwetye
Journal:  Radiographics       Date:  2016 Jul-Aug       Impact factor: 5.333

Review 5.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

6.  Hsp90-Tau complex reveals molecular basis for specificity in chaperone action.

Authors:  G Elif Karagöz; Afonso M S Duarte; Elias Akoury; Hans Ippel; Jacek Biernat; Tania Morán Luengo; Martina Radli; Tatiana Didenko; Bryce A Nordhues; Dmitry B Veprintsev; Chad A Dickey; Eckhard Mandelkow; Markus Zweckstetter; Rolf Boelens; Tobias Madl; Stefan G D Rüdiger
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

7.  Ginsenoside Rg1 decreases neurofibrillary tangles accumulation in retina by regulating activities of neprilysin and PKA in retinal cells of AD mice model.

Authors:  Yanhui He; Haijun Zhao; Guanfang Su
Journal:  J Mol Neurosci       Date:  2013-11-28       Impact factor: 3.444

8.  Hydration water mobility is enhanced around tau amyloid fibers.

Authors:  Yann Fichou; Giorgio Schirò; François-Xavier Gallat; Cedric Laguri; Martine Moulin; Jérôme Combet; Michaela Zamponi; Michael Härtlein; Catherine Picart; Estelle Mossou; Hugues Lortat-Jacob; Jacques-Philippe Colletier; Douglas J Tobias; Martin Weik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

9.  The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.

Authors:  Georges Mairet-Coello; Julien Courchet; Simon Pieraut; Virginie Courchet; Anton Maximov; Franck Polleux
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

Review 10.  Invasive and non-invasive therapies for Alzheimer's disease and other amyloidosis.

Authors:  Gaurav Pandey; Vibin Ramakrishnan
Journal:  Biophys Rev       Date:  2020-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.